scholarly journals Docetaxel and Exisulind in Previously Treated Non-small Cell Lung Cancer (NSCLC) Patients: A Multicenter, Phase II Clinical Trial

2007 ◽  
Vol 2 (10) ◽  
pp. 933-938 ◽  
Author(s):  
Glen J. Weiss ◽  
Everett E. Vokes ◽  
Paul A. Bunn ◽  
Lyn Magree ◽  
Jason Rusk ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Multicenter Phase ◽  
Previously Treated ◽  
Nsclc Patients

A phase II clinical trial of the CDK 4/6 inhibitor palbociclib (PD 0332991) in previously treated, advanced non-small cell lung cancer (NSCLC) patients with inactivated CDKN2A.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 8077-8077 ◽  
Author(s):  
Priya Kadambi Gopalan ◽  
Mary Colleen Pinder ◽  
Alberto Chiappori ◽  
Alison Marguerite Ivey ◽  
Andres Gordillo Villegas ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Small Cell Lung ◽  
Previously Treated ◽  
Nsclc Patients

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

1994 ◽  
Vol 12 (3) ◽  
pp. 243-249 ◽  
Author(s):  
Dong M. Shin ◽  
Paul Y. Holoye ◽  
Arthur Forman ◽  
Rodger Winn ◽  
Roman Perez-Soler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Didemnin B ◽  
Small Cell Lung ◽  
Previously Treated

Randomized, multicenter phase II study of erlotinib (E) or E plus fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. TPS216-TPS216 ◽  
Author(s):  
E. B. Garon ◽  
S. M. Dubinett ◽  
F. F. Kabbinavar ◽  
K. L. Reckamp ◽  
D. C. Marquez-Garban ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Multicenter Phase ◽  
Previously Treated

Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients

2016 ◽  
Vol 78 (3) ◽  
pp. 509-515 ◽  
Author(s):  
Ankit Madan ◽  
Benjamin S. Jones ◽  
Rodolfo Bordoni ◽  
Mansoor N. Saleh ◽  
Mary S. Jerome ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Previously Treated ◽  
Nsclc Patients

A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer

Lung Cancer ◽  
2004 ◽  
Vol 43 (3) ◽  
pp. 329-333 ◽  
Author(s):  
Sofia Agelaki ◽  
Marinos Veslemes ◽  
Kostas Syrigos ◽  
Filippos Palamidas ◽  
Aristidis Polyzos ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Multicenter Phase ◽  
Previously Treated Patients ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document